La MSD ha minacciato azioni legali contro l'epidemiologo clinico Alberto Donzelli, per indurlo a cessare di esprimere critiche nei confronti dell'uso di un prodotto dell'azienda.
Assume connotati internazionali la controversia tra la Merck Sharp & Dohme e il Dottor Alberto Donzelli, responsabile appropriatezza clinica della ASL di Milano. Il BMJ ha pubblicato un articolo che riassume la vicenda.
La filiale italiana della compagnia farmaceutica Merck Sharp & Dohme (MSD) ha stoppato un medico di primo piano nella gestione della salute pubblica intimandogli di cessare di indirizzare ai Medici di Medicina Generale testi medici critici nei confronti dell'uso di uno dei farmaci della società.
Nei testi, Alberto Donzelli, il capo della formazione, appropriatezza e medicina basata sulle evidenze presso l'azienda di sanità pubblica di Milano (ASL Milano), aveva analizzato le prove pubblicate sul farmaco ezetimibe scoraggiandone l'uso in aggiunta alle statine.
Una lettera a "cessare e desistere" è stata inviata in febbraio dal direttore medico di MSD, Patrizia Nardini, ed è stata recapitata dal direttore degli affari legali della società. Hanno accusato Donzelli di colpa grave e di una violazione dell'etica medica e minacciato di far causa a lui e a Milano Sanità per una cifra di € 1,3 milioni (1 milione di sterline; $ 1.78m). La lettera era indirizzata a Donzelli, con copia inviata al direttore generale della ASL di Milano e al presidente dell'Ordine dei Medici di Milano Roberto Carlo Rossi. aggiornamento, ricerca, supporto, promozione del ruolo dei medici.
A Michigan oncologist who falsely diagnosed cancer in patients and gave them unnecessary chemotherapy so as to bill Medicare for millions of dollars faces up to 215 years of consecutive prison sentences after pleading guilty to 16 counts of healthcare fraud, conspiracy, and money laundering.
The carcinogenic effect of radiofrequency electromagnetic fields in humans remains controversial. However, it has been suggested that they could be involved in the aetiology of some types of braintumours.
The objective was to analyse the association between mobilephone exposure and primary central nervous system tumours (gliomas and meningiomas) in adults.
CERENAT is a multicenter case-control study carried out in four areas in France in 2004-2006. Data about mobilephone use were collected through a detailed questionnaire delivered in a face-to-face manner. Conditional logistic regression for matched sets was used to estimate adjusted ORs and 95% CIs.
A total of 253 gliomas, 194 meningiomas and 892 matched controls selected from the local electoral rolls were analysed. No association with braintumours was observed when comparing regular mobilephone users with non-users (OR=1.24; 95% CI 0.86 to 1.77 for gliomas, OR=0.90; 95% CI 0.61 to 1.34 for meningiomas). However, the positive association was statistically significant in the heaviest users when considering life-long cumulative duration (≥896 h, OR=2.89; 95% CI 1.41 to 5.93 for gliomas; OR=2.57; 95% CI 1.02 to 6.44 for meningiomas) and number of calls for gliomas (≥18,360 calls, OR=2.10, 95% CI 1.03 to 4.31). Risks were higher for gliomas, temporal tumours, occupational and urban mobilephone use.
These additional data support previous findings concerning a possible association between heavy mobilephone use and braintumours.
At the end of last month, this Editor questioned the efficacy of our current state of ‘consumer engagement’ in Patients should be less engaged, not more. The ‘less engaged’ was a call for simplification: regimens and devices which were easier to use, less complicated and far easier to fit in everyday life. (Aesthetics helps too.) Back in 2013, HeartSister/Ethical Nag(and Canadian) Carolyn Thomas called for health app (and by inference consumer engagement) designers to ‘skate to where the puck is going’–as in “For Pete’s sake, go find some Real Live Patients to talk (and listen) to first before you decide where you’re going!” Often it seems like these apps and platforms are designed in a vacuum of the entrepreneur’s making. The proof is the low uptake (Pew, Parks, IMS) and the apps’/programs’ lack of stickiness after all this time (Kvedar 8 Sep blog post).
- See more at: http://telecareaware.com/is-digital-health-neglecting-the-big-preventable-medical-errors/#sthash.6A75LT9J.dpuf
Using a weighted average of the 4 studies, a lower limit of 210,000 deaths per year was associated with preventable harm in hospitals. Given limitations in the search capability of the Global Trigger Tool and the incompleteness of medical records on which the Tool depends, the true number of premature deaths associated with preventable harm to patients was estimated at more than 400,000 per year. Serious harm seems to be 10- to 20-fold more common than lethal harm.
We conducted a systematic review of primary, quantitative, observational studies, published in English or French, that used geographic or market-basket approaches in high-income countries. The literature search included electronic and hand searches and peer-reviewed and grey literature from 1966 through 2007. We also contacted key researchers to identify other studies. We analyzed the findings and quality of the studies qualitatively.
Hospitals feed cancer patients sugar and high carbohydrate diets for a reason: they are abysmally ignorant of the role of nutrition in health and disease — hence their burgeoning growth and packed rooms.
Even though the science itself shows – at least since the mid-’20s with Otto Warburg’s cancer hypothesis – that tumors prefer to utilize sugar fermentation to produce energy rather than the much more efficient oxygen-based phosphorylation* – hospitals have actually invited corporations like McDonald’s to move into their facilities to ‘enhance’ their patient’s gustatory experience, presumably to provide comfort and take the edge off of the painful surgery, radiation and chemo treatments erroneously proffered to them as the only reasonable ‘standard of care.’
Quelque 12 personnes ont été arrêtées lors d'une opération européenne lundi, au cours de laquelle plusieurs millions de fausses pilules contre les troubles érectiles, plusieurs véhicules et beaucoup d'argent ont été saisis.
Professor Drici said: “So-called ‘energy drinks’ are popular in dance clubs and during physical exercise, with people sometimes consuming a number of drinks one after the other. This situation can lead to a number of adverse conditions including angina, cardiac arrhythmia (irregular heartbeat) and even sudden death.”
In an investigation by The BMJ Deborah Cohen finds that recommendations for use of new generation oral anticoagulants may be flawed because regulators did not see evidence showing that monitoring drug plasma levels could improve safety
Conclusion—Diabetes prevention requires changes to societies and therefore a concerted global public health approach. Diagnoses and thresholds for clinical application may unrealistically burden societies in exchange for limited value
Don’t expect the doctor to diagnose you via social media anytime soon. A June 2014 study by MedData Group found that 44% of US physicians still weren’t using social media sites for professional purposes.
Among doctors who were social networking as part of their job, profession-related sites were the platforms of choice. Around one-third of respondents used LinkedIn, and 29% were active on online physician communities, compared with just 3% who used online patient portals. Social sites that tend to be popular among the general public also saw low usage.
Avoiding social media wasn’t due to a lack of knowledge, with less than one-quarter of doctors saying they didn’t use such platforms because they weren’t familiar with them. Instead, patient privacy and a lack of time were the leading reasons US physicians said they stayed away from using social networks for professional purposes.
Q1 2014 polling by Digital Insights Group found that the general consensus among physicians was that social just wasn’t an important resource when it came to doing their jobs. Just 14% of US primary care physicians said that social networks were a somewhat or very important clinical resource, compared with 30% who said they weren’t important at all.
When doctors do turn to digital resources to make decisions, they’re most likely using search engines, according to April 2014 research also conducted by MedData Group. Among US physicians surveyed, a whopping 78% said search engines were the online resource they used in the medical decision-making process. Meanwhile, just 5% cited social media.
Fascinante manière qu’a Google d’avancer ses pions dans tous les domaines qui importent aux humains. L’entreprise aime les «coups de pied à la lune» : les projets qui cherchent à résoudre des «problèmes graves» avec des méthodes radicalement nouvelles. Et des problèmes graves, s’il y a bien un endroit où il s’en trouve, c’est en médecine. Google y progresse donc, l’esprit conquérant. Il y avait eu le projet Calico, dévoilé l’année dernière, dont le but est de lutter contre le vieillissement et même de «tuer la mort» (problème grave et difficile, c’est vrai).
In a nationally representative sample, higher patient satisfaction was associated with less emergency department use but with greater inpatient use, higher overall health care and prescription drug expenditures, and increased mortality.
It’s one thing when my patients tell me that they are eating extra calcium to help their fractures heal or prevent new ones, but when my colleagues are advising them the same thing, its time to correct the bias. Taking calcium and/or vitamin D to heal fractures and prevent new fractures is another case of something that sounds good and is easy to believe, but doesn’t work as advertised.
Sounds like a no-brainer, right? After all, bones are made of calcium. Unfortunately, the usual combination of medical hubris, conclusion jumping, a desire to help, and some unintended consequences have turned this simple idea into a bad one. I am reminded of the quote from H.L. Mencken “For every complex problem, there is an answer that is clear, simple and wrong”
After bruising legal fight, tobacco companies agreed in 1998 to compensate 46 states, the District of Columbia and five U.S. territories for the costs of smoking. Wall Street helped them turn those annual payments into instant cash, but some took high-risk deals that promised to repay billions in the future. This map shows where your state stands.
$15 or $30? Health reporter Charles Ornstein is charged two different prices for the same drug. Which one is right? His effort to find out illustrates consumer frustrations with the health care system.
Editors' Note: Grabenhenrich and Roll critique the methodology and design in the study by Kerti et al. on the association between glucose metabolism and memory performance. The authors conduct additional statistical analysis to support their results. Neurology's sometime neuromythologist and historian, William Landau, cites quotations from Parkinson's historical monograph to comment on the article by Bohnen et al. on gait speed in Parkinson disease. The authors respond.—Chafic Karam, MD, and Robert C. Griggs, MD